secwatch / observer
8-K filed November 7, 2024, 6:59 PM ET ticker LAB CIK 0001162194
leadership confidence high sentiment neutral materiality 0.40

Standard BioTools appoints Alex Kim as CFO; COO role eliminated

STANDARD BIOTOOLS INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Alex Kim

Chief Financial Officer
LAB · STANDARD BIOTOOLS INC.
Effective
2024-11-11
Filed
November 7, 2024, 6:59 PM ET
On November 6, 2024, the Board of Directors of Standard BioTools Inc. (the “Company”) appointed Alex Kim, who has been serving as the Company’s Interim Chief Financial Officer since September 1, 2024, as the Company’s fulltime Chief Financial Officer, effective as of November 11, 2024 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alex Kim was appointed as Chief Financial Officer at STANDARD BIOTOOLS INC..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On November 6, 2024, the Board of Directors of Standard BioTools Inc. (the “Company”) appointed Alex Kim, who has been serving as the Company’s Interim Chief Financial Officer since September 1, 2024, as the Company’s fulltime Chief Financial Officer, effective as of November 11, 2024 (the “Effective Date”).
View on SEC.gov

STANDARD BIOTOOLS INC. filing history →

Source: SEC EDGAR
accession 0000950170-24-122823
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.